 Darren Gregory
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stevens-Johnson Syndrome | 10 | 2018 | 34 | 2.230 |
Why?
| | Amnion | 7 | 2017 | 24 | 1.580 |
Why?
| | Conjunctival Diseases | 7 | 2017 | 17 | 1.570 |
Why?
| | Dry Eye Syndromes | 7 | 2023 | 28 | 1.340 |
Why?
| | Corneal Diseases | 4 | 2018 | 34 | 0.750 |
Why?
| | Phacoemulsification | 2 | 2014 | 107 | 0.740 |
Why?
| | Glucocorticoids | 4 | 2022 | 535 | 0.640 |
Why?
| | Education, Medical, Graduate | 2 | 2014 | 374 | 0.630 |
Why?
| | Ophthalmology | 3 | 2015 | 77 | 0.550 |
Why?
| | Eyelid Diseases | 2 | 2016 | 21 | 0.500 |
Why?
| | Internship and Residency | 2 | 2014 | 941 | 0.430 |
Why?
| | Teaching | 1 | 2014 | 221 | 0.390 |
Why?
| | Learning Curve | 1 | 2011 | 63 | 0.360 |
Why?
| | Acute Disease | 5 | 2016 | 915 | 0.360 |
Why?
| | Clinical Competence | 2 | 2014 | 899 | 0.310 |
Why?
| | Anti-Bacterial Agents | 1 | 2016 | 1477 | 0.280 |
Why?
| | Visual Acuity | 4 | 2016 | 274 | 0.280 |
Why?
| | Blindness, Cortical | 1 | 2003 | 5 | 0.230 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2003 | 85 | 0.220 |
Why?
| | Masks | 1 | 2023 | 46 | 0.220 |
Why?
| | Lens Implantation, Intraocular | 2 | 2014 | 57 | 0.200 |
Why?
| | Pre-Eclampsia | 1 | 2003 | 165 | 0.190 |
Why?
| | Tobramycin | 2 | 2022 | 47 | 0.190 |
Why?
| | Cyclosporine | 2 | 2022 | 161 | 0.180 |
Why?
| | Epithelium, Corneal | 2 | 2018 | 37 | 0.180 |
Why?
| | Cryopreservation | 2 | 2011 | 92 | 0.160 |
Why?
| | Ophthalmic Solutions | 1 | 2018 | 66 | 0.150 |
Why?
| | Serum | 1 | 2018 | 57 | 0.150 |
Why?
| | Cicatrix | 1 | 2017 | 50 | 0.140 |
Why?
| | Fluorophotometry | 1 | 2016 | 3 | 0.140 |
Why?
| | Explosions | 1 | 2016 | 11 | 0.140 |
Why?
| | Eye Burns | 1 | 2016 | 11 | 0.140 |
Why?
| | Sclera | 1 | 2016 | 35 | 0.130 |
Why?
| | Lacerations | 1 | 2016 | 28 | 0.130 |
Why?
| | Fluoroquinolones | 1 | 2016 | 41 | 0.130 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1127 | 0.130 |
Why?
| | Blast Injuries | 1 | 2016 | 42 | 0.130 |
Why?
| | Humans | 21 | 2023 | 115044 | 0.130 |
Why?
| | Corneal Injuries | 1 | 2016 | 34 | 0.130 |
Why?
| | Female | 13 | 2023 | 59614 | 0.120 |
Why?
| | Hutchinson's Melanotic Freckle | 1 | 2015 | 1 | 0.120 |
Why?
| | Eyelid Neoplasms | 1 | 2015 | 8 | 0.120 |
Why?
| | Melanosis | 1 | 2015 | 13 | 0.120 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2016 | 72 | 0.120 |
Why?
| | Cryotherapy | 1 | 2015 | 16 | 0.120 |
Why?
| | Guidelines as Topic | 1 | 2016 | 245 | 0.120 |
Why?
| | Tissue Preservation | 2 | 2011 | 13 | 0.120 |
Why?
| | Dexamethasone | 1 | 2016 | 317 | 0.120 |
Why?
| | Operative Time | 1 | 2014 | 106 | 0.110 |
Why?
| | Hospital Costs | 1 | 2014 | 103 | 0.110 |
Why?
| | Operating Rooms | 1 | 2014 | 86 | 0.110 |
Why?
| | Prospective Studies | 2 | 2016 | 6232 | 0.100 |
Why?
| | Brain | 1 | 2003 | 2380 | 0.100 |
Why?
| | Orbital Diseases | 1 | 2012 | 25 | 0.100 |
Why?
| | Microsurgery | 1 | 2012 | 60 | 0.100 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2012 | 57 | 0.100 |
Why?
| | Disease Management | 1 | 2015 | 563 | 0.100 |
Why?
| | Male | 10 | 2023 | 55731 | 0.100 |
Why?
| | Child, Preschool | 5 | 2022 | 9093 | 0.090 |
Why?
| | Hospitals, Teaching | 1 | 2011 | 103 | 0.090 |
Why?
| | Severity of Illness Index | 2 | 2016 | 2551 | 0.090 |
Why?
| | Physician's Role | 1 | 2010 | 199 | 0.080 |
Why?
| | Adipose Tissue | 1 | 2012 | 558 | 0.080 |
Why?
| | Conjunctivitis | 1 | 2008 | 17 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1398 | 0.080 |
Why?
| | Chronic Disease | 1 | 2013 | 1591 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1353 | 0.070 |
Why?
| | Scleritis | 1 | 2007 | 18 | 0.070 |
Why?
| | Conjunctiva | 1 | 2007 | 51 | 0.070 |
Why?
| | Aged | 3 | 2014 | 19119 | 0.070 |
Why?
| | Prevalence | 2 | 2022 | 2255 | 0.070 |
Why?
| | Incidence | 2 | 2022 | 2318 | 0.070 |
Why?
| | Child | 5 | 2022 | 18407 | 0.060 |
Why?
| | Surgical Flaps | 1 | 2007 | 121 | 0.060 |
Why?
| | Adolescent | 4 | 2022 | 17864 | 0.060 |
Why?
| | Tears | 1 | 2023 | 14 | 0.060 |
Why?
| | Time Factors | 1 | 2014 | 6141 | 0.060 |
Why?
| | Meibomian Glands | 1 | 2022 | 7 | 0.050 |
Why?
| | Lubricant Eye Drops | 1 | 2022 | 4 | 0.050 |
Why?
| | Loteprednol Etabonate | 1 | 2022 | 6 | 0.050 |
Why?
| | Cornea | 1 | 2023 | 107 | 0.050 |
Why?
| | Adult | 4 | 2022 | 30656 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2017 | 9122 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2021 | 161 | 0.050 |
Why?
| | Cataract | 1 | 2022 | 185 | 0.040 |
Why?
| | Middle Aged | 2 | 2016 | 26827 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2022 | 499 | 0.040 |
Why?
| | Suture Techniques | 2 | 2012 | 118 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 582 | 0.040 |
Why?
| | Cranial Nerve Diseases | 1 | 2018 | 42 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1214 | 0.040 |
Why?
| | Facial Injuries | 1 | 2016 | 17 | 0.030 |
Why?
| | Research Design | 1 | 2021 | 930 | 0.030 |
Why?
| | Young Adult | 1 | 2011 | 10498 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2022 | 3015 | 0.030 |
Why?
| | Retrospective Studies | 3 | 2018 | 12547 | 0.030 |
Why?
| | Necrosis | 1 | 2016 | 210 | 0.030 |
Why?
| | Epidermis | 1 | 2016 | 149 | 0.030 |
Why?
| | Eye Diseases | 1 | 2016 | 76 | 0.030 |
Why?
| | Aminoquinolines | 1 | 2015 | 20 | 0.030 |
Why?
| | Infant | 2 | 2018 | 7946 | 0.030 |
Why?
| | Administration, Topical | 1 | 2015 | 138 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2003 | 2341 | 0.030 |
Why?
| | Interferon-alpha | 1 | 2015 | 186 | 0.030 |
Why?
| | Mothers | 1 | 2018 | 652 | 0.030 |
Why?
| | Prolapse | 1 | 2012 | 5 | 0.030 |
Why?
| | Fibrin Tissue Adhesive | 1 | 2012 | 13 | 0.030 |
Why?
| | Tissue Adhesives | 1 | 2012 | 17 | 0.030 |
Why?
| | Pregnancy | 1 | 2003 | 5521 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1237 | 0.020 |
Why?
| | Skin | 1 | 2016 | 659 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 4411 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2012 | 4420 | 0.020 |
Why?
| | Biological Dressings | 1 | 2010 | 2 | 0.020 |
Why?
| | Stem Cell Transplantation | 1 | 2010 | 149 | 0.020 |
Why?
| | Wound Healing | 1 | 2009 | 259 | 0.020 |
Why?
| | Quality of Life | 1 | 2016 | 2359 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2015 | 6357 | 0.010 |
Why?
| | Arthritis, Rheumatoid | 1 | 2007 | 1002 | 0.010 |
Why?
|
|
Gregory's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|